Listing delays, traditional retail format may be driving Temasek to sell Watsons

By
Posted

A.S. Watson’s focus remains on physical stores in a market where online shopping has grown much more rapidly than in the rest of the world.

Temasek

How Japanese drugmaker Takeda’s $62b Shire deal reshapes pharma world

By

It’s part of a larger shift in the industry as drugmakers scramble to consolidate, seeking to bulk up to survive the increasing pressure from stricter regulations on drug prices and looming patent expirations.


Guest post: What does 2019 have in store for Southeast Asia?

By

Here are Momentum Works’ 10 predictions for 2019 ranging from ride-hailing and payments to e-commerce and venture capital.


Huawei plays a game of musical chairs with its top executives

By

In most Western companies, the chairmanship is a functional position on a board of directors. At Huawei, it’s an honorific title that recognizes seniority and service.


Indian govt’s crackdown on Amazon, Walmart likely to hurt online shoppers

By

The government says the changes will promote fair trade and curb foreign companies’ influence in setting domestic prices. This means that platforms offered by e-commerce giants such as Amazon and Walmart’s Flipkart may be prohibited from offering their own goods at heavy discounts.


Record funding, epic shakeups dominated global tech themes in 2018

By

Investments in tech startups are set to surpass $200B this year, the largest since dot-com bubble


Bike-sharing firm Ofo’s dramatic fall a warning to China’s tech investors

By

Ofo’s plight is a warning for China’s tech investors, who have plowed tens of billions of dollars into bike sharing, ride hailing and food delivery.


Grab may shed asset-light model, add inventory, thanks to strategic partner Toyota

By

The Singapore-based ride-hailing company had just landed $1 billion in funding from Toyota Motor Corp, and the deal looked a little like vendor financing.


China’s $856b startup juggernaut causes headache

By

The basic problem is that too much capital is chasing after too few startups, something even China’s State Council is starting to realize.


India: How Hindustan Unilever clinched GSK Consumer Healthcare deal

By

An unrivalled all-stock offer is what it took Hindustan Unilever Ltd to stave off several suitors for GlaxoSmithKline Consumer Healthcare Ltd.